Hi solusnauta. What you have hit upon is "the holy grail" IMO,...

Hi solusnauta. What you have hit upon is "the holy grail" IMO, and it is something I have questioned PRR management about. The following is an email I sent to Dr Frazer in August last year:

"Hi Neil,

After doing some research, I have come to realize CVac's potential as a preventative, rather than a theraputic, vaccine.
Can you answer any of the following questions for me?

- Have you done any testing pre chemotherapy? No
- If so, can you tell me what the results were?
- If not, do you plan on conducting these trials in the future? After we obtain approval, we may broaden out the times of administration in additional clinical studies.
- What would be the proccess required to gain FDA approval, ie full PH I, II AND III? It's a difficult question. We'd probably need to start with concomitant administration with chemotherapy and work back from there.
- Will the current Ph III testing only allow you to administer CVac post chemotherapy? For EU, US and Australia-Yes"

One day...hopefully...surely...common sense will prevail.